01 July 2022 | NewsLow flu vaccination rates leaving Australians vulnerable Read the full article
Australia’s first population-level antibody study designed to shed light on how many people have contracted COVID-19 confirms that only a very small proportion – less than one percent – of Sydneysiders had been infected by the SARS-CoV-2 virus after the first epidemic wave.
Experts say the findings show the success of measures taken to date in NSW to control the virus’s spread – but also the importance of people being vigilant and continuing to come forward for testing, given that the vast majority of people remain vulnerable to the infection.
The study involved analyses of more than 5,330 de-identified blood samples from three different groups of people. If the results are extrapolated to Sydney’s five-million-strong population, it would suggest only one in 670 (or 7,450) of the city’s residents had been infected during the first wave in Sydney. While this is 3.5 times as high as the 2,118 COVID-19 cases detected and officially notified at the time, it represents a much lower level of community infection, and a lower ratio of undetected to detected infections, than seen in many international studies.
The study was co-led by NCIRS, the Kirby Institute at UNSW, and NSW Health Pathology’s Institute of Clinical Pathology and Medical Research (ICPMR). It was conducted in collaboration with Australian Red Cross Lifeblood and public and private diagnostic laboratories across Sydney, with support from the NSW Ministry of Health.
Read the full media release
Read the full study on MJA website
Declaration: This study was funded by the NSW Ministry of Health. The authors declare no competing interests.
For further information and interviews with Professor Kristine Macartney and Associate Professor Heather Gidding, please email: SCHN-NCIRSMedia@health.nsw.gov.au
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2022 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS